Clinical prognostic factors in case of skin melanoma
Abstract
The authors have studied 5 and 10-year survival of 430 patients with primary skin melanoma undergone treatment in the oncological departments of the Khabarovsk Krai in 1990-2003. The most unfavourable prognosis appeared to occur for men with the tumours localized on the head and neck and both sexes in case of foot skin lesions. There was a large number of ulcerated melanoma. The ulceration rate directly correlated to the extent of primary tumour dissemination, and was an important universal prognostic factor. Given the ulceration, it considerably worsened the situation. The occurrence of de novo tumours and melanomas in the Khabarovsk Krai was approximately equal. In case of de novo melanoma, the prognosis for the disease was more unfavourable. This factor was more evident with respect to women.
About the Authors
A. Yu. Marochko
Khabarovsk Branch of the Russian Oncological Scientific Centre named after N.N. Blokhin, RAMS
Russian Federation
Russian Federation
T. F. Borovskaya
Khabarovsk Branch of the Russian Oncological Scientific Centre named after N.N. Blokhin, RAMS
Russian Federation
Russian Federation
Yu. V. Soboleva
Khabarovsk Regional Clinical Oncologic Centre
Russian Federation
Russian Federation
References
1. Анисимов В.В. Меланома кожи (перспективы улучшения диагностики и лечения): дис.. д-ра мед. наук. СПб., 2000. 97 с.
2. Ганина К.П., Налескина Л.А. Злокачественная меланома и предшествующие изменения кожи. Киев: Наукова Думка, 1991. 167 с.
3. Марочко А.Ю. Особенности клинического течения невогенной меланомы кожи и возникшей de novo // Дальневосточный медицинский журнал. 2009. № 2. С. 39-41.
4. Фрадкин С.З., Залуцкий И.В. Меланома кожи. Минск: Беларусь, 2000. 221 с.
5. Averbook B.J., Fu P., Rao J.S., Mansour E.G. A long-term analysis of 1018 pa-tients with melanoma by classic Coxregression and treestructured survival analysis at a major referral center: Implications on the future of cancer staging // Surgery. 2002. Vol. 32, No. 4. P. 589-602.
6. Balch C.M. Cutaneous melanoma. St. Louis Missouri, 1998. 596 p.
7. Balch C.M., Bizaid A.C., Soong S.J. et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma // J. Clin. Oncol. 2001. Vol.19, No. 16. P. 3635-3648.
8. Bennet D.R., Wasson D., McArthur J.D. et al. The effect of misdiagnosis and delay in diagnosis on clinical outcome in melanomas of the foot// J. Am. Coll. Surg. 1994. Vol. 179. P. 279-282.
9. Buzaid A.C., Ross M., Balch C.M. et al. Critical analysis of the current Ameri-can Joint Committee on Cancer staging system for cutaneous melanoma and pro-posal of a new staging system // J. Clin. Oncol. 1997. Vol. 15. P. 1039-1051.
10. Clarc W.H., Goldman L.I., Mastrangelo M.J. Human malignant melanoma. New York etc.: Grune and Stratton, 1979. 509 p.
11. Kashani-Sabet M., Shaikh L., Miller J.R. et al. NF-{Kappa}B in the Vascular Progression of Melanoma // J. Clin. Oncol. 2004. Vol. 22, No. 4. P. 617-623.
12. Meier F., Will S., Ellwanger U. et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma // Br. J. Dermatol. 2002. Vol. 147, No. 1. P. 62-70.
Review
For citations:
Marochko A.Yu., Borovskaya T.F., Soboleva Yu.V. Clinical prognostic factors in case of skin melanoma. Pacific Medical Journal. 2011;(1):86-89. (In Russ.)
Views:
268
Email this article 